Targeted Therapeutics Market

Nov 2021| PHM257A| BCC Publishing
Sample Report

Report Highlights

The global market for targeted therapeutics should grow from $100.9 billion in 2021 to $142.6 billion by 2026, at a compound annual growth rate (CAGR) of 7.2% during the forecast period of 2021-2026.

Report Includes

  • 24 data tables and 29 additional tables
  • An overview of the global market for targeted therapeutics within the biopharmaceuticals sector
  • Analyses of the global market trends, with data from 2019-2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026
  • Evaluation of current market size and market forecast for targeted therapeutics, technological advancements, and corresponding market share analysis by type, application and geographic region
  • Detailed description of the target-specific functionality, advantages of target therapeutics, their production and processes, and discussion on their ability to provide therapeutic treatments for various chronic diseases
  • Coverage of disease and economic burden of cancer, types of cancer therapy and insights into cancer treatment strategy timeline
  • Insight into global R&D activities related to oncology drugs, industry structure, product launches, clinical trials, and regulatory scenario affecting the future marketplace
  • Competitive landscape and pipeline analysis of the key companies operating in the global market, their company share analysis, and relevant oncology drug licensing deals and M&A deals
  • Company profiles of major industry players, including Amgen Inc., AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb (BMS), F. Hoffmann-La Roche Ltd., Pfizer, Novartis, Merck & Co., and Takeda Pharmaceutical Co., Ltd.

Report Scope

The scope of this study entails the worldwide market for targeted therapeutics. The report covers the entire market for targeted therapeutics, which incorporates two main types, small molecules and monoclonal antibodies. Based on application, targeted therapeutics is divided into lung cancer, breast cancer, blood cancer, colorectal cancer and others.

By geography, the market has been divided into four regions: North America, Europe, Asia-Pacific and the Rest of the World. Detailed analyses of major countries: the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India are covered. For market estimates, data has been provided for the year 2020 as the base year, with forecasts for 2021-2026. Estimated values are based on drug manufacturer total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.

Analyst Credentials

BCC Publishing Staff comprises expert analysts who are skilled in conducting primary research, secondary research and data analysis and have decades of combined experience covering a wide range of industries, including healthcare, advanced materials and emerging technologies. Collectively, the team represents a diverse set of educational achievements with individual graduate work completed in fields such as microbiology, electrical engineering, business administration and surgery, among others.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at
Title/Chapter NamePagesPrice Member Price
Full Report: Targeted Therapeutics Market156 $5,500 Free
Chapter- 1: Introduction6Free DownloadFree
Chapter- 2: Summary and Highlights2$250Free
Chapter- 3: Market Overview18$647Free
Chapter- 4: Impact of COVID-19 on Market3$108Free
Chapter- 5: Regulatory Aspects7$252Free
Chapter- 6: Market Breakdown by Type of Targeted Therapy13$467Free
Chapter- 7: Market Breakdown by Application22$791Free
Chapter- 8: Market Breakdown by Region28$1,007Free
Chapter- 9: Industry Structure18$647Free
Chapter- 10: Company Profiles36$1,294Free
Chapter- 11: Appendix: Acronyms3$108Free
Targeted Therapeutics Market

Single User License: $5500

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries

Need a custom data table, graph or complete report? Tell us more.